Systemic Lupus Erythematosus Therapeutics – Pipeline Analysis, Clinical Trials and Results, Patents

Systemic lupus erythematosus (SLE) is a chronic disease that causes inflammation of cartilage and blood vessels. Pain and swelling in joints, sensitivity to sun, unexplained fever, joints and muscle pain, mouth ulcers, swollen glands, and others are some common symptoms of the...

Read More

Niemann-Pick Disease Type C NPC Therapeutics Pipeline Analysis, Clinical Trials and Results, Patents

 Niemann-Pick disease is divided into four main types: type A, type B, type C1, and type C2. These types are classified on the basis of genetic cause and signs and symptoms of the disease. NPC is identified as a rare genetic disorder in which the body is unable to transport...

Read More

Wnt Signaling Pathway Inhibitors - Pipeline Analysis, Clinical Trials & Results

Wnt signaling pathway plays an important role in embryonic development. The signaling pathway regulates cell-to-cell interaction, accelerates trophoblast development, activates blastocyst, accelerate chorion-allantois fusion and implantation. A wide range of diseases, such as...

Read More

Akt/Protein Kinase B (PKB) Inhibitors - Analysis by Stages, Drug Class, Company Profile, & Discovery Stage Insights

Akt/Protein Kinase B (PKB) Inhibitors - Pipeline Analysis, Clinical Trials & Results, Patents, Designations, Collaborations, and Other Developments published by Pharma Proff Akt/PKB inhibitors therapeutics currently exhibits a proliferating pipeline with 23 therapeutic candidates.  Akt...

Read More